PT2558079T - Composição de xarope seco de ciprofloxacina - Google Patents
Composição de xarope seco de ciprofloxacinaInfo
- Publication number
- PT2558079T PT2558079T PT10778730T PT10778730T PT2558079T PT 2558079 T PT2558079 T PT 2558079T PT 10778730 T PT10778730 T PT 10778730T PT 10778730 T PT10778730 T PT 10778730T PT 2558079 T PT2558079 T PT 2558079T
- Authority
- PT
- Portugal
- Prior art keywords
- syrup composition
- dry syrup
- ciprofloxacin
- ciprofloxacin dry
- composition
- Prior art date
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title 2
- 229960003405 ciprofloxacin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000006188 syrup Substances 0.000 title 1
- 235000020357 syrup Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1199MU2010 | 2010-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2558079T true PT2558079T (pt) | 2019-09-05 |
Family
ID=43384622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT10778730T PT2558079T (pt) | 2010-04-12 | 2010-06-03 | Composição de xarope seco de ciprofloxacina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130115300A1 (pt) |
| EP (1) | EP2558079B1 (pt) |
| AU (1) | AU2010351281B2 (pt) |
| CA (1) | CA2802142C (pt) |
| NZ (1) | NZ603545A (pt) |
| PT (1) | PT2558079T (pt) |
| WO (1) | WO2011128906A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3804531A1 (en) | 2019-10-11 | 2021-04-14 | Begapinol Dr. Schmidt GmbH | Granulation of topinambur |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6029682B2 (ja) | 1980-07-11 | 1985-07-12 | 山之内製薬株式会社 | 苦味のない製剤用組成物およびその製造法 |
| US4670444B1 (en) | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| DE4200821A1 (de) | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| IN191239B (pt) | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
| WO2001035930A1 (en) * | 1999-11-16 | 2001-05-25 | Ranbaxy Laboratories Limited | Taste masked oral compositions |
| CA2440069A1 (en) | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
| JP2005516020A (ja) | 2001-12-20 | 2005-06-02 | ファルマシア・コーポレーション | ゼロ次持続放出剤形およびその製造方法 |
| CN1688292A (zh) | 2002-09-04 | 2005-10-26 | 兰贝克赛实验室有限公司 | 掩味剂型及其制造方法 |
| WO2004087111A1 (en) * | 2003-04-04 | 2004-10-14 | Ranbaxy Laboratories Limited | Oral taste masked pharmaceutical compositions |
| US20100029743A1 (en) * | 2006-09-27 | 2010-02-04 | Dr. Reddy's Laboratories Ltd. | Atorvastatin pharmaceutical compositions |
-
2010
- 2010-06-03 PT PT10778730T patent/PT2558079T/pt unknown
- 2010-06-03 CA CA2802142A patent/CA2802142C/en not_active Expired - Fee Related
- 2010-06-03 US US13/697,452 patent/US20130115300A1/en not_active Abandoned
- 2010-06-03 AU AU2010351281A patent/AU2010351281B2/en not_active Ceased
- 2010-06-03 WO PCT/IN2010/000367 patent/WO2011128906A1/en not_active Ceased
- 2010-06-03 EP EP10778730.1A patent/EP2558079B1/en not_active Not-in-force
- 2010-06-03 NZ NZ603545A patent/NZ603545A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2558079B1 (en) | 2019-05-22 |
| NZ603545A (en) | 2013-10-25 |
| US20130115300A1 (en) | 2013-05-09 |
| CA2802142A1 (en) | 2011-10-20 |
| AU2010351281A1 (en) | 2012-11-29 |
| WO2011128906A1 (en) | 2011-10-20 |
| CA2802142C (en) | 2020-03-10 |
| EP2558079A1 (en) | 2013-02-20 |
| AU2010351281B2 (en) | 2014-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201002983D0 (en) | Nutritinal composition | |
| GB201006200D0 (en) | Composition | |
| GB201021186D0 (en) | Composition | |
| ZA201304189B (en) | Novel pharmaceutical composition | |
| PL2579859T3 (pl) | Kompozycja stała zawierająca iwabradynę | |
| GB201006178D0 (en) | Composition | |
| GB201021269D0 (en) | Composition | |
| GB201017048D0 (en) | Composition | |
| GB201021836D0 (en) | Topical Composition | |
| ZA201206841B (en) | Novel composition | |
| GB201016970D0 (en) | Composition | |
| ZA201303199B (en) | Herbicicdal composition | |
| PL2625258T3 (pl) | Kompozycja do czyszczenia z polimerów | |
| GB201019988D0 (en) | Composition | |
| GB201007531D0 (en) | Composition | |
| GB201006214D0 (en) | Composition | |
| GB201005927D0 (en) | Improved composition | |
| GB201006204D0 (en) | Composition | |
| GB201004717D0 (en) | Composition | |
| GB201014967D0 (en) | Composition | |
| GB201010657D0 (en) | Composition | |
| GB201300858D0 (en) | Topical Composition | |
| PL2534235T3 (pl) | Kompozycja | |
| GB201018130D0 (en) | Composition | |
| GB201006175D0 (en) | Composition |